Whole Body MRI in Oncology

Launched by ISTITUTO ROMAGNOLO PER LO STUDIO DEI TUMORI DINO AMADORI IRST S.R.L. IRCCS · Mar 19, 2025

Keywords

ClinConnect Summary

This clinical trial, called "Whole Body MRI in Oncology," is studying how effective a special type of MRI scan is for patients with certain types of cancers, including lymphoma, advanced prostate cancer, and multiple myeloma, among others. The goal is to see how this full-body imaging test can help doctors track the progress of these conditions. The study involves multiple centers, and all patients will receive care as usual without any extra visits or procedures that aren't part of standard practice.

To be eligible for the trial, patients must be at least 18 years old and have a life expectancy of more than three months. They should also be candidates for a whole-body MRI based on their doctor's recommendation. However, patients with certain medical devices that are unsafe for MRI or those whose MRI tests are of poor quality will not be included. If you decide to participate, you'll be contributing to important research that could improve cancer care for many people.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Patients candidate to WB-MRI according to clinical practice belonging to the study groups listed above.
• • Participant is willing and able to give informed consent for participation in the study.
• • Male or Female, aged ≥ 18 years.
• • Life expectancy greater than 3 months.
• Exclusion Criteria:
• • Patients with MRI-unsafe prostheses and devices.
• • Patients whose tests are of suboptimal quality, or whose test has been suspended, or is incomplete.